Pulsed Electromagnetic Field Treatment for Alzheimer's Disease
This study is testing a device called the ECHS AD Device, which uses pulsed electromagnetic therapy, for people with mild to moderate Alzheimer's disease. Researchers want to see if this treatment can slow down the disease's progression. You might be able to join if you are between 50 and 100 years old, have mild to moderate Alzheimer's, and have at least an eighth-grade education. The study will measure changes in your thinking and memory using tests like the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) and the Mini-Mental State Exam (MMSE). The current status of this study is unclear, and it plans to enroll 40 participants.
- Study design
- This is an open-label pilot study, meaning everyone knows they are receiving the active treatment. It plans to enroll 40 participants with mild to moderate Alzheimer's disease.
- What's involved
- You would treat yourself at home with the ECHS AD Device three times a day for 15 minutes over 120 days. Your thinking and memory will be assessed at several points over 400 days.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 9 months after the 120-day treatment period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)Change between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days
Assessment consisting of 11 tasks, taking up to 30mins, to measure the severity of cognitive dementia symptoms. Score 0-70, Higher number, more severity.
- Mini-Mental Status Exam (MMSE)Change between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days
Clinician assessment of cognitive impairment. Scoring 0-30, lower score, more severity
- Global Deterioration questionnaireChange between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days
Clinician assessment of cognitive impairment. Scored 0-7, higher score, greater severity
- Quality of Life ScaleChange between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days
Clinician assessment of cognitive impairment. Scored 0-7, higher score, greater severity